Search research articles
Contact Us
Filters
Showing results (71-80 of 96) with videos related to
Page
of 10
Sort By:
European Journal of Haematology
|
September 1, 1994
Partial characterization of human leukemia U-937 cell sublines resistant to 9-nitrocamptothecin
P Pantazis, J T Mendoza, A DeJesus, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 11, 2006
Labd-14-ene-8,13-diol (sclareol) induces cell cycle arrest and apoptosis in human breast cancer cells and enhances the activity of anticancer drugs
K Dimas, M Papadaki, C Tsimplouli, et al.
Cancer Research
|
December 15, 1991
Camptothecin and its derivatives induce expression of the c-jun protooncogene in human myeloid leukemia cells
S Kharbanda, E Rubin, H Gunji, et al.
Oncology Research
|
January 1, 1993
Efficacy of camptothecin congeners in the treatment of human breast carcinoma xenografts
P Pantazis, A J Kozielski, D M Vardeman, et al.
Oncogene
|
August 30, 2000
Susceptibility to apoptosis is restored in human leukemia HCW-2 cells following induction and stabilization of the apoptotic effector Bak
D Chatterjee, P Pantazis, G Li, et al.
Chemotherapy
|
April 29, 2006
Differential susceptibility to etoposide in clones derived from a human ovarian cancer cell line
K V Balan, N M Sitaras, K Dimas, et al.
The Journal of Biological Chemistry
|
August 22, 2001
A Fas-associated death domain protein-dependent mechanism mediates the apoptotic action of non-steroidal anti-inflammatory drugs in the human leukemic Jurkat cell line
Z Han, P Pantazis, J H Wyche, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
October 28, 1997
Monocytic differentiation of HL-60 promyelocytic leukemia cells correlates with the induction of Bcl-xL
D Chatterjee, Z Han, J Mendoza, et al.
Anticancer Research
|
September 1, 1995
Development of human leukemia U-937 cell sublines resistant to doxorubicin: induction of differentiation and altered sensitivities to topoisomerase-directed drugs
P Pantazis, A Dejesus, J Early, et al.
International Journal of Cancer
|
March 12, 1993
Camptothecin derivatives induce regression of human ovarian carcinomas grown in nude mice and distinguish between non-tumorigenic and tumorigenic cells in vitro
P Pantazis, A J Kozielski, J T Mendoza, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 96) with videos related to
Sort By:
Page
of 10
European Journal of Haematology
|
September 1, 1994
Partial characterization of human leukemia U-937 cell sublines resistant to 9-nitrocamptothecin
P Pantazis, J T Mendoza, A DeJesus, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 11, 2006
Labd-14-ene-8,13-diol (sclareol) induces cell cycle arrest and apoptosis in human breast cancer cells and enhances the activity of anticancer drugs
K Dimas, M Papadaki, C Tsimplouli, et al.
Cancer Research
|
December 15, 1991
Camptothecin and its derivatives induce expression of the c-jun protooncogene in human myeloid leukemia cells
S Kharbanda, E Rubin, H Gunji, et al.
Oncology Research
|
January 1, 1993
Efficacy of camptothecin congeners in the treatment of human breast carcinoma xenografts
P Pantazis, A J Kozielski, D M Vardeman, et al.
Oncogene
|
August 30, 2000
Susceptibility to apoptosis is restored in human leukemia HCW-2 cells following induction and stabilization of the apoptotic effector Bak
D Chatterjee, P Pantazis, G Li, et al.
Chemotherapy
|
April 29, 2006
Differential susceptibility to etoposide in clones derived from a human ovarian cancer cell line
K V Balan, N M Sitaras, K Dimas, et al.
The Journal of Biological Chemistry
|
August 22, 2001
A Fas-associated death domain protein-dependent mechanism mediates the apoptotic action of non-steroidal anti-inflammatory drugs in the human leukemic Jurkat cell line
Z Han, P Pantazis, J H Wyche, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
October 28, 1997
Monocytic differentiation of HL-60 promyelocytic leukemia cells correlates with the induction of Bcl-xL
D Chatterjee, Z Han, J Mendoza, et al.
Anticancer Research
|
September 1, 1995
Development of human leukemia U-937 cell sublines resistant to doxorubicin: induction of differentiation and altered sensitivities to topoisomerase-directed drugs
P Pantazis, A Dejesus, J Early, et al.
International Journal of Cancer
|
March 12, 1993
Camptothecin derivatives induce regression of human ovarian carcinomas grown in nude mice and distinguish between non-tumorigenic and tumorigenic cells in vitro
P Pantazis, A J Kozielski, J T Mendoza, et al.
Page
of 10